Vivani Medical, Inc.
VANI
$0.935
-$0.055-5.56%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.86% | -13.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.05% | -8.77% | |||
| Operating Income | -11.05% | 8.77% | |||
| Income Before Tax | -12.79% | 11.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.79% | 11.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.79% | 11.31% | |||
| EBIT | -11.05% | 8.77% | |||
| EBITDA | -11.04% | 8.93% | |||
| EPS Basic | -12.33% | 15.90% | |||
| Normalized Basic EPS | -12.34% | 15.91% | |||
| EPS Diluted | -12.33% | 15.90% | |||
| Normalized Diluted EPS | -12.34% | 15.91% | |||
| Average Basic Shares Outstanding | 0.41% | 5.40% | |||
| Average Diluted Shares Outstanding | 0.41% | 5.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
